What We Do
For better health,
Since 1999, ToolGen has been a leading gene editing company worldwide. After developing ZFN (Zinc Finger Nuclease) and TALEN (Transcription Activator Like Effector Nuclease), ToolGen further came up with CRISPR-Cas9. ToolGen has business in patent monetization (Licensing and Collaboration), therapeutics, and crops.
ToolGen leads the gene editing industry through the optimized CRISPR-Cas9 technology and research on various CRISPR-Cas9 related platforms. By doing so, ToolGen develops more efficient and precise gene editing technologies, contributing to the technological advancement of the industry.
We conduct research to develop treatments for genetic diseases and rare diseases so that humanity can lead a healthy life free from illness.
We conduct research to improve the traits of major crops by editing their genetic information, aiming to achieve a prosperous life without food shortages.